title: [Reply to commentary on "Rituximab in thrombocytopenic purpura..."].
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Zambrano-Velarde
authors.forename: Daniel
authors.initials: D
authors.lastname: de la O-Peña
authors.forename: Quetzalcóatl
authors.initials: Q
authors.lastname: Chávez-Peña
authors.forename: Martín
authors.initials: M
authors.lastname: Bedolla-Barajas
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors